We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Renovaro Issues Shareholder Letter and Provides Corporate Update LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics...
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in...
Renovaro Announces Strategic Restructuring and Leadership Transition Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full...
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics Strategic partnership aims to further develop Cube’s award-winning...
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection Assessment by specialist AI team from “PersonalAIze”...
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress AMSTERDAM, Sept. 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) RenovaroCube...
RenovaroCube Announces Strategic Offering of Up to 20% Ownership AMSTERDAM, Sept. 11, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) The Board of Renovaro, Inc (RENB) intends to seek strategic...
Renovaro, Inc. Announces $10 million in Equity Committed LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in...
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) and the...
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.251 | 53.6324786325 | 0.468 | 0.468 | 0.468 | 1550 | 0.468 | DE |
4 | 0.187 | 35.1503759398 | 0.532 | 0.532 | 0.468 | 860 | 0.47432558 | DE |
12 | 0.187 | 35.1503759398 | 0.532 | 0.901 | 0.3995 | 2897 | 0.59071719 | DE |
26 | -0.695 | -49.1513437058 | 1.414 | 1.792 | 0.3995 | 3202 | 1.05561359 | DE |
52 | -2.281 | -76.0333333333 | 3 | 4.3 | 0.3995 | 1962 | 1.33849569 | DE |
156 | -2.341 | -76.5032679739 | 3.06 | 4.88 | 0.3995 | 1789 | 1.79569588 | DE |
260 | -2.341 | -76.5032679739 | 3.06 | 4.88 | 0.3995 | 1789 | 1.79569588 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions